Molecular Mechanism of Alzheimer's Disease
Alzheimer’s disease (AD) is an age-related neurological disease that affects tens of millions of people, in addition to their carers. Hallmark features of AD include plaques composed of amyloid beta, as well as neurofibrillary tangles of tau protein. However, despite more than a century of study, th...
Saved in:
| : | |
|---|---|
| Year of Publication: | 2019 |
| Language: | English |
| Physical Description: | 1 electronic resource (228 p.) |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| LEADER | 03880nam-a2201189z--4500 | ||
|---|---|---|---|
| 001 | 993548257504498 | ||
| 005 | 20231214133409.0 | ||
| 006 | m o d | ||
| 007 | cr|mn|---annan | ||
| 008 | 202102s2019 xx |||||o ||| 0|eng d | ||
| 020 | |a 3-03921-408-X | ||
| 035 | |a (CKB)4100000010106213 | ||
| 035 | |a (oapen)https://directory.doabooks.org/handle/20.500.12854/53845 | ||
| 035 | |a (EXLCZ)994100000010106213 | ||
| 041 | 0 | |a eng | |
| 100 | 1 | |a Macreadie, Ian |4 auth | |
| 245 | 1 | 0 | |a Molecular Mechanism of Alzheimer's Disease |
| 260 | |b MDPI - Multidisciplinary Digital Publishing Institute |c 2019 | ||
| 300 | |a 1 electronic resource (228 p.) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 520 | |a Alzheimer’s disease (AD) is an age-related neurological disease that affects tens of millions of people, in addition to their carers. Hallmark features of AD include plaques composed of amyloid beta, as well as neurofibrillary tangles of tau protein. However, despite more than a century of study, the cause of Alzheimer’s disease remains unresolved. The roles of amyloid beta and tau are being questioned and other causes of AD are now under consideration. The contributions of researchers, model organisms, and various hypotheses will be examined in this Special Issue. | ||
| 546 | |a English | ||
| 653 | |a HOTAIR | ||
| 653 | |a neurosciences | ||
| 653 | |a sleep disturbance | ||
| 653 | |a positron emission tomography (PET) | ||
| 653 | |a vitamin B complex | ||
| 653 | |a neurodegeneration | ||
| 653 | |a Tau | ||
| 653 | |a miR-15/107 | ||
| 653 | |a default-mode network | ||
| 653 | |a complement receptor 1 | ||
| 653 | |a neuronal differentiation | ||
| 653 | |a epigenetics | ||
| 653 | |a brain glucose metabolism | ||
| 653 | |a oligomerization | ||
| 653 | |a genetic risk | ||
| 653 | |a A?O receptors | ||
| 653 | |a prion | ||
| 653 | |a ryanodine receptor | ||
| 653 | |a type 3 diabetes | ||
| 653 | |a complement | ||
| 653 | |a cognitive behavioral therapy for insomnia | ||
| 653 | |a cognitive function | ||
| 653 | |a epigenome-wide association study | ||
| 653 | |a Alzheimer’s disease | ||
| 653 | |a calcium signaling | ||
| 653 | |a ?-secretase | ||
| 653 | |a tau | ||
| 653 | |a Prolyl isomerases | ||
| 653 | |a NEAT1 | ||
| 653 | |a complement C3b/C4b receptor | ||
| 653 | |a proteostasis | ||
| 653 | |a amyloid beta | ||
| 653 | |a yeast | ||
| 653 | |a slow-wave sleep | ||
| 653 | |a amyloid ? | ||
| 653 | |a nutrition | ||
| 653 | |a 4 | ||
| 653 | |a protein aggregation | ||
| 653 | |a apolipoprotein E | ||
| 653 | |a dementia | ||
| 653 | |a MALAT1 | ||
| 653 | |a inositol 1 | ||
| 653 | |a lncRNAs | ||
| 653 | |a molecular biology | ||
| 653 | |a methylenetetrahydrofolate reductase MTHFR gene | ||
| 653 | |a 5-trisphosphate receptor | ||
| 653 | |a CR1 density | ||
| 653 | |a miR-34c | ||
| 653 | |a aggregation | ||
| 653 | |a heat shock protein | ||
| 653 | |a dendritic spine | ||
| 653 | |a S-adenosylmethionine | ||
| 653 | |a beta amyloid | ||
| 653 | |a ion channel | ||
| 653 | |a inflammation | ||
| 653 | |a sleep fragmentation | ||
| 653 | |a cystathionine-?-lyase CTH gene | ||
| 653 | |a DNA methylation | ||
| 653 | |a heat shock response | ||
| 653 | |a microglia | ||
| 653 | |a drug target discovery | ||
| 653 | |a amyloid-? oligomer | ||
| 653 | |a therapy | ||
| 653 | |a CR1 length polymorphism | ||
| 653 | |a methylome | ||
| 653 | |a APOE gene | ||
| 653 | |a ubiquitin | ||
| 653 | |a magnetic resonance imaging (MRI) | ||
| 653 | |a neuronal degeneration | ||
| 653 | |a type 2 diabetes | ||
| 653 | |a Pin1 | ||
| 653 | |a mild cognitive impairment | ||
| 653 | |a dairy products | ||
| 653 | |a endoplasmic reticulum | ||
| 653 | |a oxidative stress | ||
| 653 | |a Hispanics | ||
| 653 | |a CDK5R1 | ||
| 776 | |z 3-03921-407-1 | ||
| 906 | |a BOOK | ||
| ADM | |b 2023-12-15 05:52:55 Europe/Vienna |f system |c marc21 |a 2020-02-01 22:26:53 Europe/Vienna |g false | ||
| AVE | |i DOAB Directory of Open Access Books |P DOAB Directory of Open Access Books |x https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338799830004498&Force_direct=true |Z 5338799830004498 |b Available |8 5338799830004498 | ||